A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung Cancer
Not Applicable
- Conditions
- locally advanced Non-small cell Lung Cancer
- Registration Number
- JPRN-UMIN000023802
- Lead Sponsor
- Hirosaki University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1) T3N1 2) Superior vena cava syndrome. 3) Lymph node metastases of opposite side hilum, malignant pleuritis, malignant pericarditis, lymphangitis. 4) With active double cancer. 5) Active infection. 6) Other serious disease condition (idiopathic pulmonary fibrosis, interstitial lung disease, renal failure, liver failure, Cerebral Vascular Disorder, unstable angina, cardiac infarction, Myocardial Infarction, poorly controlled diabetes mellitus,etc). 7) Grade2< peripheral neuropathy. 8) Severe drug allergy. 9) Pregnancy or lactation. 10) Patient whose participation in the trial is judged to be inappropriate by the attending doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method